Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | RORB | Q92753 | 3/20 | 0.34 |
| ▸ | RORC | P51449 | 2/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21870515 | 0.84 | TOP2A (0.42) | RORBRORCSCN9A | |
| SCHEMBL23557316 | 0.83 | TOP2A (0.38) | S1PR1S1PR3 | |
| SCHEMBL26606380 | 0.83 | S1PR1 (0.40) | S1PR1S1PR3RORBRORCNOTUM | |
| SCHEMBL22167050 | 0.78 | S1PR1 (0.38) | S1PR1NOTUM | |
| SCHEMBL22167064 | 0.78 | CCNT1 (0.32) | SCN9A | |
| SCHEMBL22167066 | 0.76 | RPS6KA3 (0.31) | — | |
| SCHEMBL25848923 | 0.75 | DYRK1A (0.32) | — | |
| SCHEMBL15856975 | 0.73 | IKBKB (0.36) | — | |
| SCHEMBL28616202 | 0.73 | KDM4E (0.38) | — | |
| SCHEMBL25669673 | 0.73 | KDM4E (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | UBE2L3, CRY1, OR10J3 | S1PR1 4405/4885S1PR3 4291/4885RORB 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.